Public consultation on interim decisions to amend the Poisons Standard - ACMS, ACCS & Joint ACMS-ACCS NOVEMBER, 2023

While the consultation is open you can make a submission at our TGA consultation hub.

We review the submissions carefully. After that the submissions and our decision will be available on the same page at the TGA consultation hub.

Overview

Interim decisions regarding substances discussed at the expert advisory meetings. 

This consultation is for interim decisions made in relation to substances that were discussed at the NOVEMBER 2023 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

The interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 17 April 2024. All submissions received by the deadline will be considered by the delegate before they make an interim decision.

The interim decisions under consultation are detailed in the Public notice of interim decisions NOVEMBER 2023 which can be accessed below: 

• Notice of interim decisions on proposed amendments to the Poisons Standard – ACMS #43, ACCS #37 and Joint ACMS-ACCS #35 - November 2023 

Substances for which public comment is sought:

ACMS:

• ASTODRIMER SODIUM
• BILASTINE
• BPC-157
• GLYCOPYRRONIUM
• METHENAMINE
• NARATRIPTAN
• PARACETAMOL

ACCS:

• ANIMAL BLOOD PRODUCTS
• BILE ACIDS

JOINT ACMS-ACCS:

• ADRENALINE
• BENZOIC ACID
• MELOXICAM
• PALMITOYLETHANOLAMIDE (PEA)

DELEGATE-ONLY DECISION:

• CAPROMORELIN

All current TGA consultations can be found at the TGA consultation hub.